Nestlé India Under FSSAI Scrutiny Over Infant Products and Marketing Claims
The FSSAI has taken action against Nestlé India for alleged non-compliance for three baby nutrition products – NAN Excella Pro Stage 1, Lactogen Pro 1 and another formula. The cases, which claimed violations of India’s baby nourishment rules, are still being adjudicated.
The Food Safety and Standards Authority of India (FSSAI) took action against Nestle India Limited on September 18th due to three infant nutrition items that were allegedly non-compliant. The legal notification states that the case involves Nestle India's NAN Excella Pro Stage 1, Lactogen Pro 1, and a subsequent formula.
As part of its investigations, the FSSAI looked into the goods and advertising on online marketplaces. The regulatory body voiced its disapproval of specific product advertising claims and discovered an error in the nutritional makeup of one of the formula samples used for further testing.
Why Nestle in a Soup?
The litigation notification states that "5 HMOs" and "Whey Protein" were mentioned in the advertising materials for NAN Excella Pro Stage 1. Concerned by these assertions, FSSAI contacted Nestle India to request clarification. After further investigation, the relevant authority determined that the product had violated the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020, specifically Regulation 4(2). Marketing materials for Lactogen Pro 1 were also reviewed by FSSAI.
The content supposedly said that whey protein is easy to digest. The product was found to be in violation of both the 2020 requirements and Regulation 4(2), which the authority sought clarification from Nestle India about. The goal of the regulation is to limit advertising tactics for baby food. Please be advised that Nestle products are not prohibited. Accusation of non-compliance is the subject of the FSSAI action, as stated in the notice. The products have not been banned, or that every batch is hazardous, only because proceedings have been initiated. The competent authority's conclusions and the adjudication proceedings will determine the final decision.
Strict Scanning on Infant Nutrition Products
Due to the special needs of infants during a critical developmental period, infant nutrition products are regulated more stringently than other types of food. Advertising and promotional materials for baby foods are limited in India by law to avoid the potential influence of marketing on feeding habits. The Infant Milk Substitutes, Feeding Bottles and Infant Foods (Regulation of Production, Supply and Distribution) Act, 1992, is also referenced in the FSSAI notice.
Certain infant foods and milk replacements are not allowed to be advertised or promoted under certain legal circumstances. According to the notice, Neste India Limited is facing three distinct adjudication cases involving these three goods. There are three cases concerning biotin content-related test findings, two of which include purported infractions regarding advertising claims. Cases like these go through an adjudication procedure, which means the proper authorities will look into the accusations of wrongdoing before deciding on a final punishment.
